Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
38.5M
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
5.78M
-
Shares change
-
-290K
-
Total reported value, excl. options
-
$14.6M
-
Value change
-
-$924K
-
Put/Call ratio
-
0.37
-
Number of buys
-
21
-
Number of sells
-
-30
-
Price
-
$2.52
Significant Holders of Co-Diagnostics, Inc. - Common Stock (CODX) as of Q4 2022
72 filings reported holding CODX - Co-Diagnostics, Inc. - Common Stock as of Q4 2022.
Co-Diagnostics, Inc. - Common Stock (CODX) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.78M shares
of 38.5M outstanding shares and own 14.99% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.78M shares), RENAISSANCE TECHNOLOGIES LLC (654K shares), BlackRock Inc. (539K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (438K shares), MORGAN STANLEY (367K shares), GEODE CAPITAL MANAGEMENT, LLC (319K shares), AMERICAN CENTURY COMPANIES INC (213K shares), Bank of New York Mellon Corp (184K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (128K shares), and EASTERLY INVESTMENT PARTNERS LLC (124K shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.